Related Experiment Video
Updated: Jan 9, 2026
Regulation of Hormone Secretion
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease
A Di Sabatino1, C L Jackson, K M Pickard
1First Department of Medicine, Fondazione IRCCS Policlinico S. Matteo, Centro per lo Studio e la Cura delle Malattie Infiammatorie Croniche Intestinali, University of Pavia, Pavia, Italy.
Background And Aims:
In addition to its crucial role in dampening tissue-damaging immune responses in the gut, transforming growth factor beta (TGFbeta) is a potent profibrogenic agent inducing collagen synthesis and regulating the balance between matrix-degrading matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). TGFbeta signalling was investigated by analysis of Smad proteins and MMPs/TIMPs in the mucosa overlying strictures in patients with Crohn's disease (CD).
Methods:
Specimens were collected from macroscopically normal mucosa overlying strictured and non-strictured gut of patients with fibrostenosing CD. Isolated myofibroblasts were cultured with anti-TGFbeta blocking antibody or TGF beta 1. TGFbeta transcripts were analysed by quantitative reverse transcription-PCR (RT-PCR). Smad proteins and MMPs were determined by immunoblotting. MMP-12 activity was measured by a real-time MMP-12 activity assay. An in vitro wound-healing scratch assay was used to assess myofibroblast migration.
Results:
TGFbeta transcripts, phosphorylated Smad2-Smad3 (pSmad2-3) and TIMP-1 proteins were higher in mucosa overlying strictures than in mucosa overlying non-strictured areas. In contrast, mucosa overlying strictured gut had lower expression of Smad7, MMP-12 and MMP-3. Myofibroblasts from mucosa overlying strictured gut showed higher TGFbeta transcripts, a greater pSmad2-3 response to TGFbeta, increased TIMP-1, lower Smad7, increased collagen production and reduced migration ability compared with myofibroblasts from mucosa overlying non-strictured gut. TGFbeta blockade increased myofibroblast MMP-12 production and migration, more obviously in myofibroblasts isolated from mucosa overlying non-strictured compared with strictured gut.
Conclusions:
Changes in TGF-beta signalling and MMP production were identified in the mucosa overlying strictures in CD which may give a window into the process of fibrosis.
Insights
Transforming growth factor beta (TGFbeta) signaling and matrix metalloproteinase (MMP) production are altered in Crohn's disease strictures. These changes in TGFbeta, Smad proteins, and MMPs/TIMPs in the gut mucosa may contribute to fibrosis.
Area of Science:
- Gastroenterology
- Immunology
- Fibrosis Research
Background:
- Transforming growth factor beta (TGFbeta) plays a dual role in the gut, modulating immune responses and promoting fibrosis.
- Fibrostenotic Crohn's disease (CD) involves complex molecular changes in the gut mucosa.
- Understanding TGFbeta signaling in CD strictures is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate TGFbeta signaling pathways, including Smad proteins, and the balance of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the mucosa overlying strictures in patients with CD.
- To analyze the expression and activity of these molecules in myofibroblasts isolated from strictures.
Main Methods:
- Analysis of TGFbeta transcripts, Smad proteins (phosphorylated Smad2-3, Smad7), and MMPs/TIMPs in mucosal biopsies from strictured and non-strictured areas of CD patients.
- Culture of myofibroblasts with TGFbeta or a TGFbeta blocking antibody.
- Quantitative reverse transcription-PCR (RT-PCR), immunoblotting, MMP activity assays, and in vitro wound-healing assays were employed.
Main Results:
- Mucosa overlying strictures showed increased TGFbeta transcripts, phosphorylated Smad2-3, and TIMP-1, but decreased Smad7, MMP-12, and MMP-3 compared to non-strictured areas.
- Myofibroblasts from strictured areas exhibited higher TGFbeta signaling, increased TIMP-1, reduced Smad7, elevated collagen production, and impaired migration.
- TGFbeta blockade enhanced MMP-12 production and migration in myofibroblasts, with a more pronounced effect in those from non-strictured areas.
Conclusions:
- Altered TGFbeta signaling and dysregulated MMP production are characteristic of the mucosa overlying strictures in Crohn's disease.
- These molecular changes provide insights into the fibrotic processes occurring in CD strictures.
- Targeting TGFbeta pathways could be a potential therapeutic strategy for managing CD-associated fibrosis.
Related Concept Videos
Regulation of Hormone Secretion
Humoral...
Hormonal Regulation
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Feedback Inhibition